When patients ask about peptides, he says, we talk about 'here's what the claims are for this peptide
SIBOtic is the antimicrobial treatment stage a high-dose, four-compound botanical formula targeting the bacterial and archaeal overgrowth that defines SIBO
CagriSema has the stronger evidence base with completed phase 3 REDEFINE trials showing 20.4% weight loss, and is closer to potential approval
Depending on your health and medication use, the injection may still be safe, or your provider may decide to reschedule to minimize epidural procedure risk
On the data side, the Lau phase 2 obesity trial showed Cagrilintide monotherapy producing dose-related weight loss, reaching close to 10.8 percent at the top dose over roughly 26 weeks, against about 3 percent on placebo
Faster delivery, no matter where you are in Australia